CSV export
Details about the neuroanatomical projections from ORBm to PERI
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91777 | Orbital area medial part | Perirhinal area | strong | biotinylated dextran amine (BDA) | The injection resulted in a dense plexus of labeled axons and axonal varicosities rostrally in PER, at the level where the dorsal hippocampus merges with the ventral hippocampus. Collator note: strong labeling in the rostral PERI, especially in layer V, with some label in layers II-III. See Fig. 4B, Swanson Atlas Levels 31-33. | Kondo H. & Witter M.P., 2014 | |
| 91779 | Orbital area medial part | Perirhinal area | light/moderate | biotinylated dextran amine (BDA) | The labeling density decreased at more rostral levels (Fig. 4A) and at more caudal levels of PER (Fig. 4C,D). Collator note: weak-moderate label in the rostralmost part of the ECT. See Fig. 4A, Swanson Atlas Levels 31-32. | Kondo H. & Witter M.P., 2014 | |
| 91781 | Orbital area medial part | Perirhinal area | light/moderate | biotinylated dextran amine (BDA) | Collator note: labeled fibers mostly in layer V, mid-rostrocaudally. See Fig. 4C, Swanson Atlas Levels 38-39. | Kondo H. & Witter M.P., 2014 | |
| 91783 | Orbital area medial part | Perirhinal area | not present | biotinylated dextran amine (BDA) | Collator note: no label in the caudal PERI and ECT. See Fig. 4D, Swanson Atlas Levels 41-42. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-25), the BDA injection involved mainly layer III, with some involvement of layers II and V, at a midrostrocaudal level of MO (Figs. 2, 3A, 4, Table 2). Collator note: the injection is mapped here onto Swanson Atlas Levels 4-5. |
Details about the neuroanatomical projections from ORBm to ECT
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91778 | Orbital area medial part | Ectorhinal area | light/moderate | biotinylated dextran amine (BDA) | Collator note: the terminal field in PERI extends for a small distance in the ventral ECT, in layers I-III. Few terminals are also seen in layer V. See Fig. 4B, Swanson Atlas Levels 31-33. | Kondo H. & Witter M.P., 2014 | |
| 91780 | Orbital area medial part | Ectorhinal area | light | biotinylated dextran amine (BDA) | Collator note: few terminals in the rostralmost part of the ECT. See Fig. 4A, Swanson Atlas Levels 31-32. | Kondo H. & Witter M.P., 2014 | |
| 91782 | Orbital area medial part | Ectorhinal area | light/moderate | biotinylated dextran amine (BDA) | Collator note: labeled fibers mostly in layers II-III, mid-rostrocaudally. See Fig. 4C, Swanson Atlas Levels 38-39. | Kondo H. & Witter M.P., 2014 | |
| 91784 | Orbital area medial part | Ectorhinal area | not present | biotinylated dextran amine (BDA) | Collator note: no label in the caudal PERI and ECT. See Fig. 4D, Swanson Atlas Levels 41-42. | Kondo H. & Witter M.P., 2014 | |
| 91787 | Orbital area medial part | Ectorhinal area | light | biotinylated dextran amine (BDA) | Collator note: weak labeling of the caudal ECT. See Fig. 4D-F, Swanson Atlas Levels 43-47. The terminals are shown mostly in layer II, and few in layer V. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-25), the BDA injection involved mainly layer III, with some involvement of layers II and V, at a midrostrocaudal level of MO (Figs. 2, 3A, 4, Table 2). Collator note: the injection is mapped here onto Swanson Atlas Levels 4-5. |
Details about the neuroanatomical projections from ORBm to ENTl
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91785 | Orbital area medial part | Entorhinal area, lateral part | light/moderate | biotinylated dextran amine (BDA) | In EC, terminal labeling was found mainly in superficial layers of the more caudal portions of the dorsal lateral and dorsal intermediate parts of LEC (Fig. 4D, E). Collator note: weak-moderate labeling of the caudal ENTl, in the ventral part. Labeled terminals are found in all layers, with concentrations in layers III and V. Swanson Atlas Levels 41-44. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-25), the BDA injection involved mainly layer III, with some involvement of layers II and V, at a midrostrocaudal level of MO (Figs. 2, 3A, 4, Table 2). Collator note: the injection is mapped here onto Swanson Atlas Levels 4-5. |
Details about the neuroanatomical projections from ORBm to POST
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91788 | Orbital area medial part | Postsubiculum | very light | biotinylated dextran amine (BDA) | Collator note: very few terminals and possible fibers of passage in the caudalmost part of the POST, as an extension of the terminal field in ECT. See fig. 4F, Swanson Atlas Levels 46-47. | Kondo H. & Witter M.P., 2014 | |
| 91793 | Orbital area medial part | Postsubiculum | very light | biotinylated dextran amine (BDA) | Collator note: very few terminals and possible fibers of passage in the rostral POST. See Fig. 10A, Swanson Atlas Levels 39-40. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-25), the BDA injection involved mainly layer III, with some involvement of layers II and V, at a midrostrocaudal level of MO (Figs. 2, 3A, 4, Table 2). Collator note: the injection is mapped here onto Swanson Atlas Levels 4-5. |
Details about the neuroanatomical projections from ORBm to RSPv-a
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91794 | Orbital area medial part | Retrosplenial area ventral part zone a | very light | biotinylated dextran amine (BDA) | Collator note: few terminals in the caudal RSPv-a. See Fig. 10A, Swanson Atlas Levels 44-45. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-25), the BDA injection involved mainly layer III, with some involvement of layers II and V, at a midrostrocaudal level of MO (Figs. 2, 3A, 4, Table 2). Collator note: the injection is mapped here onto Swanson Atlas Levels 4-5. |
Details about the neuroanatomical projections from ORBm to TEv
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91792 | Orbital area medial part | Ventral temporal association areas | not present | biotinylated dextran amine (BDA) | Collator note: no label seen in the TEA. See Fig. 4A-D, Swanson Atlas Levels 32-42. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-25), the BDA injection involved mainly layer III, with some involvement of layers II and V, at a midrostrocaudal level of MO (Figs. 2, 3A, 4, Table 2). Collator note: the injection is mapped here onto Swanson Atlas Levels 4-5. |
Details about the neuroanatomical projections from ORBm to ENTm
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91786 | Orbital area medial part | Entorhinal area medial part, dorsal zone | not present | biotinylated dextran amine (BDA) | The medial parts of LEC and MEC were not labeled (Fig. 4C–F). Collator note: ENTm is devoid of label. Swanson Atlas Levels 38-47. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-25), the BDA injection involved mainly layer III, with some involvement of layers II and V, at a midrostrocaudal level of MO (Figs. 2, 3A, 4, Table 2). Collator note: the injection is mapped here onto Swanson Atlas Levels 4-5. |
Details about the neuroanatomical projections from ORBm to PAR
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91790 | Orbital area medial part | Parasubiculum | not present | biotinylated dextran amine (BDA) | Collator note: no label shown in PAR and PRE. See Fig. 4E-F, Swanson Atlas Levels 43-47. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-25), the BDA injection involved mainly layer III, with some involvement of layers II and V, at a midrostrocaudal level of MO (Figs. 2, 3A, 4, Table 2). Collator note: the injection is mapped here onto Swanson Atlas Levels 4-5. |
Details about the neuroanatomical projections from ORBm to PRE
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91791 | Orbital area medial part | Presubiculum | not present | biotinylated dextran amine (BDA) | Collator note: no label shown in PAR and PRE. See Fig. 4E-F, Swanson Atlas Levels 43-47. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-25), the BDA injection involved mainly layer III, with some involvement of layers II and V, at a midrostrocaudal level of MO (Figs. 2, 3A, 4, Table 2). Collator note: the injection is mapped here onto Swanson Atlas Levels 4-5. |
Details about the neuroanatomical projections from ORBvl to PERI
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91795 | Orbital area ventrolateral part | Perirhinal area | very strong | biotinylated dextran amine (BDA) | this injection gave rise to a dense plexus of labeled terminal axons rostrally in PER at the fundus and the dorsal bank of the rhinal sulcus, involving dorsal area 35 and ventral area 36 (Figs. 5B, 11B). This patch of dense axonal label was located in a restricted rostrocaudal zone (less than 1 mm), where the dorsal hippocampus makes contact with the ventral hippocampus in coronal sections. Collator note: Swanson Atlas Levels 32-33. | Kondo H. & Witter M.P., 2014 | |
| 91797 | Orbital area ventrolateral part | Perirhinal area | light/moderate | biotinylated dextran amine (BDA) | Collator note: rostralmost, PERI is labeled weakly-moderate, mostly in layer VI. See Fig. 5A, Swanson Atlas Level 31. | Kondo H. & Witter M.P., 2014 | |
| 91799 | Orbital area ventrolateral part | Perirhinal area | moderate | biotinylated dextran amine (BDA) | Collator note: clear continuation of the terminal field from ECT, at least in the rostroventral part of the TEA. See Fig 5A, Swanson Atlas Level 31. | Kondo H. & Witter M.P., 2014 | |
| 91800 | Orbital area ventrolateral part | Perirhinal area | light | biotinylated dextran amine (BDA) | Labeling intensity in PER decreased at more caudal levels (Fig. 5C,D) […]. Collator note: few terminals in layers VI and III. See Fig. 5D, Swanson Atlas Levels 40-41. | Kondo H. & Witter M.P., 2014 | |
| 91819 | Orbital area ventrolateral part | Perirhinal area | moderate/strong | biotinylated dextran amine (BDA) | Caudal POR showed moderate to dense labeling of terminating axons (Figs. 6F, 12B), was also the case for the rostral PER, especially around the border between areas 35 and 36 (Fig. 6B). Collator note: moderate-strong terminal field in the dorsal PERI and ventral ECT, in layers II-III. Se Fig. 6B, Swanson Atlas Levels 32-33. | Kondo H. & Witter M.P., 2014 | |
| 91821 | Orbital area ventrolateral part | Perirhinal area | very light | biotinylated dextran amine (BDA) | Labeling in PER decreased at more rostral levels (Fig. 6A) and at more caudal levels (Fig. 6C,D). Collator note: very few labeled fibers in the rostralmost part of the PERI and ECT. See Fig. 6A, Swanson Atlas Levels 30-31. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-17), the BDA injection targeted the lateral portion of VO at a caudal level (Figs. 2, 5). The injection involved mainly layers II and III.Collator note: injection in the caudal third of the ORBvl. See Figs. 1, 2, and 5. The injection is mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBvl to ECT
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91796 | Orbital area ventrolateral part | Ectorhinal area | moderate | biotinylated dextran amine (BDA) | this injection gave rise to a dense plexus of labeled terminal axons rostrally in PER at the fundus and the dorsal bank of the rhinal sulcus, involving dorsal area 35 and ventral area 36 (Figs. 5B, 11B). This patch of dense axonal label was located in a restricted rostrocaudal zone (less than 1 mm), where the dorsal hippocampus makes contact with the ventral hippocampus in coronal sections. Collator note: the label in ECT is moderate, and in layers I-III. See Fig 5B, Swanson Atlas Levels 32-33. | Kondo H. & Witter M.P., 2014 | |
| 91798 | Orbital area ventrolateral part | Ectorhinal area | moderate/strong | biotinylated dextran amine (BDA) | Collator note: rostralmost, PERI is labeled strongly-moderate, in layers II-V. See Fig. 5A, Swanson Atlas Level 31. | Kondo H. & Witter M.P., 2014 | |
| 91801 | Orbital area ventrolateral part | Ectorhinal area | moderate/strong | biotinylated dextran amine (BDA) | Labeling intensity in PER decreased at more caudal levels (Fig. 5C,D) […]. Collator note: terminals making a distinct fieId in layer III. See Fig. 5C, Swanson Atlas Levels 33-34. | Kondo H. & Witter M.P., 2014 | |
| 91802 | Orbital area ventrolateral part | Ectorhinal area | moderate/strong | biotinylated dextran amine (BDA) | Collator note: distinct terminal field in layer III of the ECT. See Fig. 5C, Swanson Atlas Levels 33-34. | Kondo H. & Witter M.P., 2014 | |
| 91803 | Orbital area ventrolateral part | Ectorhinal area | moderate | biotinylated dextran amine (BDA) | Collator note: at least moderate labeling in the caudal ECT, mostly in layer III. See Fig. 5E, Swanson Atlas Levels 45-46. | Kondo H. & Witter M.P., 2014 | |
| 91805 | Orbital area ventrolateral part | Ectorhinal area | strong | biotinylated dextran amine (BDA) | […] dense labeling in POR, particularly in the superficial layers at more caudal levels (Figs. 5F, 12A). Collator note: dense labeling in the caudalmost part of both ECT and TEA, in layers II-III. See Fig. 5F, Swanson Atlas Levels 46-47. | Kondo H. & Witter M.P., 2014 | |
| 91820 | Orbital area ventrolateral part | Ectorhinal area | moderate/strong | biotinylated dextran amine (BDA) | Caudal POR showed moderate to dense labeling of terminating axons (Figs. 6F, 12B), was also the case for the rostral PER, especially around the border between areas 35 and 36 (Fig. 6B). Collator note: moderate-strong terminal field in the dorsal PERI and ventral ECT, in layers II-III. Se Fig. 6B, Swanson Atlas Levels 32-33. | Kondo H. & Witter M.P., 2014 | |
| 91822 | Orbital area ventrolateral part | Ectorhinal area | very light | biotinylated dextran amine (BDA) | Labeling in PER decreased at more rostral levels (Fig. 6A) and at more caudal levels (Fig. 6C,D). Collator note: very few labeled fibers in the rostralmost part of the PERI and ECT. See Fig. 6A, Swanson Atlas Levels 30-31. | Kondo H. & Witter M.P., 2014 | |
| 91824 | Orbital area ventrolateral part | Ectorhinal area | moderate | biotinylated dextran amine (BDA) | Collator note: terminal field in layers III and V, in ECT, caudalmost. See Fig. 6E, Swanson Atlas Levels 45-46. | Kondo H. & Witter M.P., 2014 | |
| 91825 | Orbital area ventrolateral part | Ectorhinal area | moderate/strong | biotinylated dextran amine (BDA) | Collator note: quite strong terminal field in the caudalmost ECT, layers II-V. See Fig. 6F, Swanson Atlas Levels 46-48. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-17), the BDA injection targeted the lateral portion of VO at a caudal level (Figs. 2, 5). The injection involved mainly layers II and III.Collator note: injection in the caudal third of the ORBvl. See Figs. 1, 2, and 5. The injection is mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBvl to ENTl
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91807 | Orbital area ventrolateral part | Entorhinal area, lateral part | light/moderate | biotinylated dextran amine (BDA) | In EC, labeled axons, passing through the deep layers of LEC (Fig. 5A–D), terminated in the upper layers of the caudal portion of the dorsal lateral LEC (Figs. 5E, 12C), and caudally adjacent caudal part of MEC (Figs. 5F, 12E). Collator note: weak-moderate labeling of the caudalmost portions of the ENTl and ENTm, respectively. The labeled terminals are located in layers II-III. See Fig. 5E-F, Swanson Atlas Levels 45-47. | Kondo H. & Witter M.P., 2014 | |
| 91826 | Orbital area ventrolateral part | Entorhinal area, lateral part | light | biotinylated dextran amine (BDA) | Collator note: field with terminals and fibers of passage restricted to the dorsal part of the central ENTl. See Fig. 6D, Swanson Atlas Levels 41-42. | Kondo H. & Witter M.P., 2014 | |
| 91827 | Orbital area ventrolateral part | Entorhinal area, lateral part | moderate | biotinylated dextran amine (BDA) | Collator note: terminal field in the caudal ENTl, with some fibers in the ventral ENTm. See Fig 6E, Swanson Atlas Levels 45-46. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-17), the BDA injection targeted the lateral portion of VO at a caudal level (Figs. 2, 5). The injection involved mainly layers II and III.Collator note: injection in the caudal third of the ORBvl. See Figs. 1, 2, and 5. The injection is mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBvl to POST
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91813 | Orbital area ventrolateral part | Postsubiculum | light/moderate | biotinylated dextran amine (BDA) | Collator note: terminals and fibers in the rostral POST. See Fig. 10B, Swanson Atlas Levels 39-40. | Kondo H. & Witter M.P., 2014 | |
| 91815 | Orbital area ventrolateral part | Postsubiculum | moderate | biotinylated dextran amine (BDA) | Collator note: a terminal field in the dorsal POST, mid-rostrocaudally. See Fig. 10B, Swanson Atlas Levels 42-43. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-17), the BDA injection targeted the lateral portion of VO at a caudal level (Figs. 2, 5). The injection involved mainly layers II and III.Collator note: injection in the caudal third of the ORBvl. See Figs. 1, 2, and 5. The injection is mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBvl to RSPv-a
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91812 | Orbital area ventrolateral part | Retrosplenial area ventral part zone a | light | biotinylated dextran amine (BDA) | Collator note: terminals and fibers in the caudal RSPv-a, close to the border with the POST. See Fig. 10B, Swanson Atlas Levels 39-40. | Kondo H. & Witter M.P., 2014 | |
| 91816 | Orbital area ventrolateral part | Retrosplenial area ventral part zone a | light/moderate | biotinylated dextran amine (BDA) | Collator note: the terminal field in POST extends for a very small distance in the ventral RSPV-a, in the superficial layers. See Fig. 10B, Swanson Atlas Levels 42-43. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-17), the BDA injection targeted the lateral portion of VO at a caudal level (Figs. 2, 5). The injection involved mainly layers II and III.Collator note: injection in the caudal third of the ORBvl. See Figs. 1, 2, and 5. The injection is mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBvl to TEv
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91804 | Orbital area ventrolateral part | Ventral temporal association areas | moderate | biotinylated dextran amine (BDA) | Collator note: terminal field in layer II, with some extension in layer V. See Fig. 5E, Swanson Atlas Levels 45-46. | Kondo H. & Witter M.P., 2014 | |
| 91806 | Orbital area ventrolateral part | Ventral temporal association areas | strong | biotinylated dextran amine (BDA) | Collator note: dense labeling in the caudalmost part of both ECT and TEA, in layers II-III. See Fig. 5F, Swanson Atlas Levels 46-47. | Kondo H. & Witter M.P., 2014 | |
| 91823 | Orbital area ventrolateral part | Ventral temporal association areas | light | biotinylated dextran amine (BDA) | Collator note: few terminals in the rostral TEA. See Fig. 6A-D, Swanson Atlas Levels 30-42. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-17), the BDA injection targeted the lateral portion of VO at a caudal level (Figs. 2, 5). The injection involved mainly layers II and III.Collator note: injection in the caudal third of the ORBvl. See Figs. 1, 2, and 5. The injection is mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBvl to ENTm
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91808 | Orbital area ventrolateral part | Entorhinal area medial part, dorsal zone | light | biotinylated dextran amine (BDA) | In EC, labeled axons, passing through the deep layers of LEC (Fig. 5A–D), terminated in the upper layers of the caudal portion of the dorsal lateral LEC (Figs. 5E, 12C), and caudally adjacent caudal part of MEC (Figs. 5F, 12E). Collator note: weak-moderate labeling of the caudalmost portions of the ENTl and ENTm, respectively. The labeled terminals are located in layers II-III. See Fig. 5E-F, Swanson Atlas Levels 45-47. | Kondo H. & Witter M.P., 2014 | |
| 91810 | Orbital area ventrolateral part | Entorhinal area medial part, dorsal zone | not present | biotinylated dextran amine (BDA) | Labeling was almost absent more medially in LEC and MEC. | Kondo H. & Witter M.P., 2014 | |
| 91828 | Orbital area ventrolateral part | Entorhinal area medial part, dorsal zone | light | biotinylated dextran amine (BDA) | Collator note: few fibers in layers I-III of the caudal ENTm, ventrally. See Fig 6E, Swanson Atlas Levels 45-46. | Kondo H. & Witter M.P., 2014 | |
| 91829 | Orbital area ventrolateral part | Entorhinal area medial part, dorsal zone | not present | biotinylated dextran amine (BDA) | Collator note: no label in the rostral ENTm. See Fig. 6C-D, Swanson Atlas Levels 39-42. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-17), the BDA injection targeted the lateral portion of VO at a caudal level (Figs. 2, 5). The injection involved mainly layers II and III.Collator note: injection in the caudal third of the ORBvl. See Figs. 1, 2, and 5. The injection is mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBvl to PAR
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91809 | Orbital area ventrolateral part | Parasubiculum | strong | biotinylated dextran amine (BDA) | Collator note: strong labeling of the caudalmost part of PAR. Other neighboring regions may be labeled, too. See Fig. 5F, Swanson Atlas Levels 46-47. | Kondo H. & Witter M.P., 2014 | |
| 91818 | Orbital area ventrolateral part | Parasubiculum | very light | biotinylated dextran amine (BDA) | Collator note: few fibers in the depth of the dorsal PAR, in this level. See Fig. 10B, Swanson Atlas Levels 42-43. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-17), the BDA injection targeted the lateral portion of VO at a caudal level (Figs. 2, 5). The injection involved mainly layers II and III.Collator note: injection in the caudal third of the ORBvl. See Figs. 1, 2, and 5. The injection is mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBvl to PRE
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91814 | Orbital area ventrolateral part | Presubiculum | light | biotinylated dextran amine (BDA) | Collator note: very few terminals, if any, in the rostral PRE, dorsally. See Fig. 10B, Swanson Atlas Levels 39-40. | Kondo H. & Witter M.P., 2014 | |
| 91817 | Orbital area ventrolateral part | Presubiculum | strong | biotinylated dextran amine (BDA) | Collator note: a strong terminal field in PRE, abutting the SUBd in this level. See Fig. 10B, Swanson Atlas Levels 42-43. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-17), the BDA injection targeted the lateral portion of VO at a caudal level (Figs. 2, 5). The injection involved mainly layers II and III.Collator note: injection in the caudal third of the ORBvl. See Figs. 1, 2, and 5. The injection is mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBl to PERI
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91832 | Orbital area lateral part | Perirhinal area | strong | biotinylated dextran amine (BDA) | a dense plexus of labeled axons and axonal varicosities in rostral PER, especially in the fundus and the dorsal bank of the rhinal sulcus, involving dorsal area 35 and ventral area 36 (Figs. 7B, 11D). Collator note: the terminal field is mostly in layer III, with some extension in layer V. See Fig. 7B, Swanson Atlas Levels 33-34. | Kondo H. & Witter M.P., 2014 | |
| 91836 | Orbital area lateral part | Perirhinal area | moderate/strong | biotinylated dextran amine (BDA) | […] labeling extended farther rostrally in this case (Fig. 7A) compared with MO (Fig. 4) and ventral VO (Fig. 6) cases. Collator note: strong-moderate label in both PERI and ECT, rostralmost. Terminals are intermingled with fibers of passage, and are distributed in layers III and V. See Fig. 7A, Swanson Atlas Levels 31-32. | Kondo H. & Witter M.P., 2014 | |
| 91837 | Orbital area lateral part | Perirhinal area | light | biotinylated dextran amine (BDA) | At more caudal levels, labeling in PER decreased in density (Fig. 7C) and was absent caudally in PER (Fig. 7D). Collator note: weak terminal field in layer III, at this level. See Fig. 7C, Swanson Atlas Levels 35-36. | Kondo H. & Witter M.P., 2014 | |
| 91839 | Orbital area lateral part | Perirhinal area | not present | biotinylated dextran amine (BDA) | At more caudal levels, labeling in PER decreased in density (Fig. 7C) and was absent caudally in PER (Fig. 7D). Collator note: Swanson Atlas Levels 42-43. | Kondo H. & Witter M.P., 2014 | |
| 91848 | Orbital area lateral part | Perirhinal area | light/moderate | biotinylated dextran amine (BDA) | The injection produced labeled axons and terminals rostrally in PER, but labeling was weak (Figs. 8A,B, 11E) or absent in the middle and caudal portions of PER (Fig. 8C–E). Collator note: weak-moderate label at best in the rostral PERI. The label is mostly in layers II-III, with very few terminals in V. See Fig. 8A-B, Swanson Atlas Levels 30-32. | Kondo H. & Witter M.P., 2014 | |
| 91849 | Orbital area lateral part | Perirhinal area | not present | biotinylated dextran amine (BDA) | The injection produced labeled axons and terminals rostrally in PER, but labeling was weak (Figs. 8A,B, 11E) or absent in the middle and caudal portions of PER (Fig. 8C–E). Collator note: no label in the caudal two thirds of the PERI. See Fig. 8C-E, Swanson Atlas Levels 35-43. | Kondo H. & Witter M.P., 2014 | |
| 91863 | Orbital area lateral part | Perirhinal area | moderate/strong | biotinylated dextran amine (BDA) | Collator note: weak-moderate field in the deep layers of the PERI, and moderate-strong in the dorsal part, extending into the ECT in this level. See Fig. 11F. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-30), the BDA injection was centered in layers II–III of VLO in the middle of the orbital surface (Figs. 2, 3C, 7, Table 2). Collator note: small BDA injection in the ORBl, centrally, mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBl to ECT
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91833 | Orbital area lateral part | Ectorhinal area | strong | biotinylated dextran amine (BDA) | a dense plexus of labeled axons and axonal varicosities in rostral PER, especially in the fundus and the dorsal bank of the rhinal sulcus, involving dorsal area 35 and ventral area 36 (Figs. 7B, 11D). Collator note: the terminal field is extending for a small portion in the ventral corner of the PERI in this level, and is mostly in layer III, with some extension in layer V. See Fig. 7B, Swanson Atlas Levels 33-34. | Kondo H. & Witter M.P., 2014 | |
| 91835 | Orbital area lateral part | Ectorhinal area | moderate/strong | biotinylated dextran amine (BDA) | […] labeling extended farther rostrally in this case (Fig. 7A) compared with MO (Fig. 4) and ventral VO (Fig. 6) cases. Collator note: strong-moderate label in both PERI and ECT, rostralmost. Terminals are intermingled with fibers of passage, and are distributed in layers III and V. See Fig. 7A, Swanson Atlas Levels 31-32. | Kondo H. & Witter M.P., 2014 | |
| 91838 | Orbital area lateral part | Ectorhinal area | very light | biotinylated dextran amine (BDA) | Collator note: very few terminals and possible fibers of passage in the central part of the ECT. See Fig. 7C, Swanson Atlas Levels 35-36. | Kondo H. & Witter M.P., 2014 | |
| 91840 | Orbital area lateral part | Ectorhinal area | light | biotinylated dextran amine (BDA) | Collator note: few terminals in the caudalmost part of the ECT. See Fig. 7E-F, Swanson Atlas Levels 44-47. | Kondo H. & Witter M.P., 2014 | |
| 91843 | Orbital area lateral part | Ectorhinal area | light/moderate | biotinylated dextran amine (BDA) | In POR, only weak labeling was present (Fig. 7F), which is distinct from that seen in VO cases. Collator note: weak-moderate labeling in the caudalmost part of the ECT, in layers II-III. See Fig. 7F, Swanson Atlas Levels 46-47. | Kondo H. & Witter M.P., 2014 | |
| 91850 | Orbital area lateral part | Ectorhinal area | light | biotinylated dextran amine (BDA) | Collator note: few terminals in layer III in the ventral corner of the rostralmost ECT. See Fig. 8A, Swanson Atlas Levels 30-31. | Kondo H. & Witter M.P., 2014 | |
| 91864 | Orbital area lateral part | Ectorhinal area | moderate/strong | biotinylated dextran amine (BDA) | Collator note: weak-moderate field in the deep layers of the PERI, and moderate-strong in the dorsal part, extending into the ECT in this level. See Fig. 11F. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-30), the BDA injection was centered in layers II–III of VLO in the middle of the orbital surface (Figs. 2, 3C, 7, Table 2). Collator note: small BDA injection in the ORBl, centrally, mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBl to ENTl
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91841 | Orbital area lateral part | Entorhinal area, lateral part | moderate | biotinylated dextran amine (BDA) | Labeling was observed caudally in the dorsal lateral LEC (Fig. 7D,E) and caudal part of MEC (Fig. 7F). Collator note: label in the caudal ENTl, Swanson parcellation scheme. The label is moderate at best, with terminals concentrated in layers II-III. See Fig. 7D-F, Swanson Atlas Levels 42-47. | Kondo H. & Witter M.P., 2014 | |
| 91852 | Orbital area lateral part | Entorhinal area, lateral part | very strong | biotinylated dextran amine (BDA) | Collator note: very strong terminal field in the rostral ENTl, covering layers III-V. See Fig. 8B-D, Swanson Atlas Levels 32-41. | Kondo H. & Witter M.P., 2014 | |
| 91853 | Orbital area lateral part | Entorhinal area, lateral part | moderate/strong | biotinylated dextran amine (BDA) | Collator note: moderate-strong terminal field in the rostral ENTl, mostly in layer V. See Fig. 8A, Swanson Atlas Levels 30-31. | Kondo H. & Witter M.P., 2014 | |
| 91854 | Orbital area lateral part | Entorhinal area, lateral part | moderate | biotinylated dextran amine (BDA) | Collator note: moderate labeling in the dorsocaudal ENTl. See Fig. 8E, Swanson Atlas Levels 42-43. | Kondo H. & Witter M.P., 2014 | |
| 91855 | Orbital area lateral part | Entorhinal area, lateral part | light | biotinylated dextran amine (BDA) | Collator note: weak labeling in the dorsocaudal ENTl. See Fig. 8F, Swanson Atlas Levels 46-47. | Kondo H. & Witter M.P., 2014 | |
| 91862 | Orbital area lateral part | Entorhinal area, lateral part | strong | biotinylated dextran amine (BDA) | Collator note: strong and delimited terminal field in the deep layers of the ENTl, rostrally. See Fig.11F. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-30), the BDA injection was centered in layers II–III of VLO in the middle of the orbital surface (Figs. 2, 3C, 7, Table 2). Collator note: small BDA injection in the ORBl, centrally, mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBl to POST
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91844 | Orbital area lateral part | Postsubiculum | light | biotinylated dextran amine (BDA) | Collator note: weak labeling of the rostral POST, continuing for a short distance in the dorsal PRE. See Fig. 10C, Swanson Atlas Levels 40-41. | Kondo H. & Witter M.P., 2014 | |
| 91858 | Orbital area lateral part | Postsubiculum | light/moderate | biotinylated dextran amine (BDA) | Collator note: a spot of terminals and labeled fibers in the rostral POST. See Fig. 10D, and 12F, Swanson Atlas Levels 39-40. | Kondo H. & Witter M.P., 2014 | |
| 91859 | Orbital area lateral part | Postsubiculum | not present | biotinylated dextran amine (BDA) | Collator note: no label in the caudal two thirds of the POST. See Fig. 10C, Swanson Atlas Levels 42-44. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-30), the BDA injection was centered in layers II–III of VLO in the middle of the orbital surface (Figs. 2, 3C, 7, Table 2). Collator note: small BDA injection in the ORBl, centrally, mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBl to RSPv-a
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91846 | Orbital area lateral part | Retrosplenial area ventral part zone a | not present | biotinylated dextran amine (BDA) | Collator note: no label of the RSPv-a, at least in these levels. See Fig. 10C, Swanson Atlas Levels 40-43. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-30), the BDA injection was centered in layers II–III of VLO in the middle of the orbital surface (Figs. 2, 3C, 7, Table 2). Collator note: small BDA injection in the ORBl, centrally, mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBl to TEv
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91834 | Orbital area lateral part | Ventral temporal association areas | light | biotinylated dextran amine (BDA) | Collator note: weak labeling in the rostral TEA. Terminals are seen in layers V, few in III, and fibers of passage in layer I. See Fig. 7B, Swanson Atlas Levels 33-34. | Kondo H. & Witter M.P., 2014 | |
| 91851 | Orbital area lateral part | Ventral temporal association areas | not present | biotinylated dextran amine (BDA) | Collator note: no label in the TEA, rostrocaudally. See Fig. 8A-F, Swanson Atlas Levels 30-47. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-30), the BDA injection was centered in layers II–III of VLO in the middle of the orbital surface (Figs. 2, 3C, 7, Table 2). Collator note: small BDA injection in the ORBl, centrally, mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBl to ENTm
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91842 | Orbital area lateral part | Entorhinal area medial part, dorsal zone | light | biotinylated dextran amine (BDA) | Labeling was observed caudally in the dorsal lateral LEC (Fig. 7D,E) and caudal part of MEC (Fig. 7F). Collator note: label in the caudalmost ENTm, Swanson parcellation scheme. The label is weak at best, with terminals concentrated in layers II-III. See Fig. 7F, Swanson Atlas Levels 46-47. | Kondo H. & Witter M.P., 2014 | |
| 91856 | Orbital area lateral part | Entorhinal area medial part, dorsal zone | not present | biotinylated dextran amine (BDA) | Collator note: no label found in this region. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-30), the BDA injection was centered in layers II–III of VLO in the middle of the orbital surface (Figs. 2, 3C, 7, Table 2). Collator note: small BDA injection in the ORBl, centrally, mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBl to PAR
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91847 | Orbital area lateral part | Parasubiculum | not present | biotinylated dextran amine (BDA) | Collator note: no label of the PAR. See Fig. 10C, Swanson Atlas Levels 40-43. | Kondo H. & Witter M.P., 2014 | |
| 91860 | Orbital area lateral part | Parasubiculum | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-30), the BDA injection was centered in layers II–III of VLO in the middle of the orbital surface (Figs. 2, 3C, 7, Table 2). Collator note: small BDA injection in the ORBl, centrally, mapped here onto Swanson Atlas Levels 5-6. |
Details about the neuroanatomical projections from ORBl to PRE
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91845 | Orbital area lateral part | Presubiculum | very light | biotinylated dextran amine (BDA) | Collator note: 2-3 labeled fibers in the dorsal corner of the PRE. See Fig. 10C, Swanson Atlas Levels 40-41. | Kondo H. & Witter M.P., 2014 | |
| 91861 | Orbital area lateral part | Presubiculum | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-30), the BDA injection was centered in layers II–III of VLO in the middle of the orbital surface (Figs. 2, 3C, 7, Table 2). Collator note: small BDA injection in the ORBl, centrally, mapped here onto Swanson Atlas Levels 5-6. |
